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ABSTRACT

Author: Esquina, Candi, M. MS
Institution: Purdue University
Degree Received: August 2018
Title: Electrostatic Regulation of Phospholipase Cb Enzymes
Committee Chair: Angeline Lyon
Phospholipase C (PLC) proteins cleave phosphatidylinositol lipids from cellular
membranes to produce the second messengers inositol triphosphate (IP3) and
diacylglycerol (DAG). The PLCb subfamily is among the best characterized of the PLC
enzymes and is crucial for normal cardiovascular function. Under basal conditions, PLCb
has low activity and is partitioned between the plasma membrane and the cytoplasm.
However, it is unclear how this low activity state is maintained from a molecular
standpoint. One known autoinhibitory element is the X–Y linker, a loop within the catalytic
domain that forms a lid over the active site and which is displaced through interfacial
activation. Autoinhibition by the X–Y linker is thought to require a highly conserved acidic
stretch of residues, as deletions encompassing this acidic region, or the entire linker, result
in increased basal activity, decreased efficacy of G protein activation, and decreased
thermal stability. These results, together with previous structural studies, suggest that the
acidic stretch may regulate basal activity in part through interactions with conserved basic
residues on the surface catalytic domain. I have used site-directed mutagenesis and
functional assays to begin establishing the contribution of intramolecular electrostatic
interactions to the regulation of PLCb.
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INTRODUCTION

1.1

Purpose of Charge Reversal Project
Phospholipase C b (PLCb) is an enzyme subfamily that plays a role in

cardiovascular function and disease (Mende et al., 1997; Filtz et al., 2009; Woodcock et
al., 2009; Grubb et al., 2012). A widely studied autoinhibitory element of PLCb has been
the X–Y linker as cleavage of this region increases activity (Schnabel and Camps 1998;
Zhang and Neer 2001; Hicks et al., 2008), and questions about how it regulates PLCb basal
activity have been raised. The work on this project aims at addressing those questions. The
X–Y linker contains an acidic residue stretch thought to have electrostatic interactions with
solvent-exposed basic residues of its triose phosphate isomerase (TIM) barrel domain
(Lyon et al., 2013). Charge reversal of the X–Y linker acidic residue stretch and TIM barrel
domain solvent-exposed basic residues will be conducted to uncover how these two regions
interact with one another. Understanding how this mechanism of PLCb regulation
functions will provide insight into its role in cardiovascular disease.

1.2

Phospholipase C Enzymes
Phospholipase C (PLC) enzymes canonically cleave the inner plasma membrane

lipid phosphatidylinositol-4,5-bisphosphate (PIP2) into the second messengers inositol1,4,5-triphosphate (IP3) and diacylglycerol (DAG) in a calcium-dependent reaction (Rhee,
2001; Hicks et al., 2008; Filtz et al., 2009). Intracellular Ca2+ is released upon IP3 binding
to IP3-specific receptors (Lyon et al., 2011) while DAG remains at the plasma membrane.
Increased intracellular Ca2+, in conjunction with DAG, leads to the stimulation of protein
kinase C (PKC). PKC activity regulates various cellular processes including cell
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contractility, motility, and proliferation (Lyon et al., 2014). The PLC family contains six
subfamilies of isozymes: b, e, d, g, h, and z (Hicks et al., 2008). The PLCb subfamily is
among the best characterized due to its role in cardiovascular disease, as changes in its
expression or activity lead to heart failure (Mende et al., 1997), hypertrophy (Filtz et al.,
2009; Grubb et al., 2012), and arrhythmias (Woodcock et al., 2009).

1.3

PLCb Domain Architecture
The phospholipase Cb (PLCb) subfamily is comprised of four isoforms: PLCb1,

PLCb2, PLCb3, and PLCb4 (Hicks et al., 2008). All share the same domain architecture,
which includes a pleckstrin homology (PH) domain, four EF hand repeats, a triose
phosphate isomerase (TIM) domain that contains the active site and the autoinhibitory X–
Y linker, a C2 domain, and the proximal and distal C-terminal domains (CTDs). The PH
domain of PLCb weakly contributes to membrane binding (Tall et al., 1997; Wang et al.,
1999b), and is thought to contribute to protein-protein interactions (Lyon et al., 2013). The
PLCb EF hands appear to act primarily as scaffolding domains, with EF hands 3 and 4
(EF3/4) responsible for stimulating the GTP hydrolysis of the heterotrimeric G protein
subunit Gaq, the best characterized activator of PLCb (Waldo et al., 2010). The TIM barrel
domain is split into X and Y regions by the autoinhibitory X–Y linker, and it houses the
active site (Lyon and Tesmer, 2013). The C2 domain interacts with the TIM barrel and EF
hands, stabilizing the overall structure of the enzyme, and contributes to Gaq binding
(Waldo et al., 2010). The proximal CTD contains the primary Gaq binding site (Waldo et
al. 2010) and the Ha2’ helix, which is also autoinhibitory (Lyon et al., 2011). The distal
CTD forms an extended coiled-coil domain aids in membrane binding (Lee et al., 1993b;
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Kim et al., 1996; Lyon et al., 2011), and contributes to Gaq binding and Gaq-stimulated
activation (Park et al., 1993; Kim et al., 1996; Adjobo-Hermans et al., 2008).
PLCb3-D892
PLCb3-D847

Figure 1.1: Domain Architecture of PLCb Enzymes
(Top) PLCb isoforms contain an N-terminal pleckstrin homology domain (PH), four EF
hand repeats, a catalytic TIM barrel split by the inhibitory X–Y linker, a C2 domain, a
proximal C-terminal domain (proximal CTD), a C-terminal domain linker (CTD linker),
and a distal CTD. Numbers above the diagram correspond to the domain boundaries of
PLCb3. (Bottom) Sequence alignment of the acidic stretch from the X–Y linkers of human
PLCb1, PLCb2, and PLCb3, with the conserved acidic residues shown in magenta. The
disordered region of X–Y linker is shown as a dashed magenta line, along with the lid helix
at the C-terminus.
1.4

Autoinhibition of PLCb
PLCb contains two known autoinhibitory elements: the X–Y linker and the Ha2’

helix. The X–Y linker splits the TIM barrel domain (Hicks et al., 2008), while the Ha2’
helix is located within the proximal CTD (Lyon et al., 2011 and 2014). Deletion or
proteolytic cleavage of the X–Y linker increases the basal activity of PLCb and some other
PLC enzymes (Schnabel and Camps 1998; Zhang and Neer 2001; Hicks et al., 2008). In
contrast, the Ha2’ helix is unique to the PLCb subfamily. Deletion or mutation of this helix
also increases basal activity and decreases thermal stability (Lyon et al., 2011).
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To determine the respective contributions of these two autoinhibitory elements, two
C-terminal truncations of PLCb3 have been characterized (Hick et al., 2008; Waldo et al.,
2010; Lyon et al., 2011). PLCb3-D847 contains only the conserved core domains (PH –
C2 domains), and lacks the proximal CTD. It is thought to be the smallest PLCb fragment
that retains lipase activity (Hicks et al., 2008). The second truncation is PLCb3-D892,
which contains both the X–Y linker domain and the Ha2’ helix from the proximal CTD
(Waldo et al., 2010; Lyon et al., 2011). The presence of the Ha2’ helix in the proximal
CTD of PLCb3-D892 results in decreased basal activity and increased thermal stability as
compared to PLCb-D847 (Lyon et al., 2011). By comparing these two variants, it is also
possible to begin to distinguish the role of the X–Y linker from that of the Ha2’ helix in
regulating basal activity.

1.5

Proposed Mechanism for Electrostatic Regulation by the X–Y Linker
The PLCb X–Y linker was first identified as a regulatory element because its

cleavage or deletion significantly increases basal activity (Zhang and Neer, 2001;Hicks et
al., 2008). While the N-terminus of the linker is unconserved and disordered, its C-terminus
contains a highly conserved acidic stretch, followed by ~15-20 conserved residues that
form a helix (Figure 1.1). This helix is in close proximity to the active site, and is thought
to inhibit activity by acting as a lid to prevent substrate binding (Hicks et al., 2008).
Therefore, in order for PLCb to bind and hydrolyze PIP2, this lid helix must be displaced.
The acidic stretch within the X–Y linker is thought to be essential to this process, as
electrostatic repulsion between this region and the negatively charged inner leaflet of the
membrane is expected to displace the lid helix (Hicks et al., 2008).
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The acidic stretch within the X–Y linker may also regulate activity through other
mechanisms. Internal deletions within the X–Y linker that include the acidic stretch, but
leave the residues that form lid helix, are sufficient to increase basal activity and decrease
thermal stability (Lyon et al., 2014). In addition, deletion of the acidic stretch also results
in the disordering of the lid helix (Lyon et al., 2014). These results suggest the acidic stretch
may help stabilize the bound conformation of the lid helix. In support of this hypothesis, a
crystal structure of the human PLCb2 catalytic core contained electron density for the last
two residues of the acidic stretch. These residues were found to be in close proximity to
several conserved basic residues on the surface of the TIM barrel domain, and thus could
form non-specific electrostatic interactions that stabilize the lid helix (Jezyk et al., 2006)
(Figure 1.2 A). Similar basic residues are observed in crystal structures of PLCb3 (46%
amino acid sequence identity), resulting in the TIM barrel domain having an overall
positive charge (Figure 1.2 C).

1.6

Characterization of Intramolecular Electrostatic Interactions in PLCb3
To further understand the role of the acidic stretch in PLCb3 autoinhibition, charge

reversal mutations were introduced in the background of the two previously characterized
C-terminal truncations, PLCb3-D847 and PLCb3-D892 (Figure 1.1). PLCb3-D847
contains the four conserved PLC core domains, and is thought to form the minimal
fragment that retains lipase activity. PLCb3-D892 contains the conserved core and the
proximal CTD. These PLCb3 fragments do not contain the distal CTD, which allows us to
directly investigate the impact of intramolecular electrostatic interactions on activity,
which could otherwise be obscured by the ability of the distal CTD to increase membrane
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binding. In addition, by comparing PLCb3-D847 and PLCb3-D892, it is possible to gain
insight into whether regulation by Ha2' helix is altered by the charge reversal mutations.
In PLCb3, the acidic stretch ranges from Glu556 to Glu566. This entire region was mutated
to

lysines

in

both

PLCb3-D847

and

PLCb3-D892

(PLCb3-D847

E556K/D557K/E558K/E559K/E560K/D561K/E562K/E563K/E564K /E565K/E566K and
PLCb3-D892

E556K/D557K/E558K/E559K/E560K/D561K/E562K

/E563K/

E564K/E565K/E566K). These variants are referred to as PLCb3-D847EK and PLCb3D892EK, respectively, for clarity (Table 2.1). The surface of the TIM barrel was mutated to
reverse the charge of the conserved, solvent-exposed basic residues Lys601, Arg611,
Lys613, and Lys624 (Waldo et al. 2010; Figure 1.2). These residues were mutated to
glutamates, generating the PLCb3-D847 K601E/R611E/K613E/K624E and PLCb3-D892
K601E/R611E/ K613E/K624E, variants (referred to as PLCb3-D847KE and PLCb3D892KE, respectively) (Table 2.1). To determine whether combining the charge reversal
mutations restored electrostatic autoinhibition, the mutants PLCb3-D847 E556566K/K601E/R611E/K613E/K624E

and

PLCb3-D892

-

E556-566K/

K601E/R611E/K613E/K624E (referred to PLCb3-D847FLIP and PLCb3-D892FLIP) were
also expressed and purified.
Further inspection of the crystal structure and sequence resulted in the identification
of additional residues on the TIM barrel surface that may also contribute to intramolecular
electrostatic interactions. These additional residues, Lys367, Lys420, and Lys610, were
also mutated to glutamates in the background of both PLCb3-D847KE and PLCb3-D847FLIP.
The

resulting

mutants,

PLCb3-D847

E556-
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566K/K367E/K420E/K601E/K610E/R611E/K613E/

K624E

and

PLCb3-D847

K367E/K420E/K601E/K610E/R611E/K613E/K624E, are referred to PLCb3-D847FLIP 3KE
and PLCb3-D847KE 3KE for clarity (Table 2.1). Finally, to ensure that any changes in
activity are due to changes in intramolecular electrostatics as opposed to membrane
binding, the residues of the acidic stretch (Glu556-566) were mutated to alanines in
PLCb3-D847

E556A/D557A/E558A/E559A/E560A/D561A/E562A/E563A/E564A

/E565A/E566A (referred to as PLCb3-D847EA) (Table 2.1).
I hypothesized that the charge reversal mutations within the acidic stretch of the X–
Y linker or the TIM barrel would increase PLCb3 basal activity due to loss of
autoinhibition. These mutations would disrupt the electrostatic interactions between the
TIM barrel and X–Y linker, promoting displacement of the lid helix from the active site,
and allowing it to bind substrate. These mutations may also decrease the stability of the
enzyme, which has been reported to increase basal activity in the case of PLCb3 (Lyon et
al., 2014). Finally, when the charges of the acidic stretch and the TIM barrel are reversed
within the same mutant, I predicted that autoinhibition would be restored. Table 1.1
contains our expected results for PLCb3-D847 and PLCb3-D892 charge reversal variants.
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A

B

C

Figure 1.2: Potential Intramolecular Electrostatic Interactions in Human PLCb2 and
PLCb3.
A. A crystal structure of the human PLCb2 catalytic core (PDB ID 2FJU; Jezyk, M. R. et
al. 2006) reveals the last two residues of the acidic stretch, Glu512 and Glu513, in close
proximity to conserved basic residues on the surface of the TIM barrel domain. These
residues are shown in ball and stick representation. Disordered regions of the X–Y linker
are represented by a pink dashed line. The catalytic calcium is shown as a black sphere.
Domains are colored as in Figure 1.1 B. Structure of human PLCb3 in the same orientation
as PLCb2 (PDB ID 3OHM; Waldo et al. 2010). Solvent exposed basic residues of the TIM
barrel are labeled and represented in ball and stick form. The catalytic calcium is shown as
a black sphere. Disordered regions of the X–Y linker are represented by a pink dashed line.
Domains are colored as in Figure 1.1. C. The electrostatic surface the human PLCb3 core,
shown in the same orientation as (B). Blue regions indicate positive potential (> +5 kT/e)
and regions in red depict negative potential (< -5 kT/e) values, where k is the Boltzmann’s
constant, T is temperature in Kelvin, and e is the charge of an electron (APBS Software;
Baker et al., 2001; Dolinsky et al., 2004; Dolinsky et al., 2007).
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Table 1.1: Table of Expected Results for PLCb3-D847 and PLCb3-D892 Charge Reversal
Variants
PLCb3 Variant

Charge Reversal Mutation

PLCb3-∆847

Wild-type control for PLCb3D847 variants
X–Y linker acidic stretch

PLCb3-∆847EK
PLCb3-∆847KE
PLCb3-∆847KE 3KE
PLCb3-∆847FLIP

PLCb3-∆847FLIP
3KE

PLCb3-∆847EA
PLCb3-∆892
PLCb3-∆892EK
PLCb3-∆892KE
PLCb3-∆892FLIP

Solvent-exposed basic residues
on TIM barrel
Solvent-exposed basic residues
on TIM barrel domain (includes
Lys367, Lys420, and Lys610)
X–Y linker acidic stretch and
solvent-exposed basic residues on
TIM barrel
X–Y linker acidic stretch and
solvent-exposed basic residues on
TIM barrel (includes Lys367,
Lys420, and Lys610)
X–Y linker acidic stretch
Wild-type control for PLCb3D892 variants
Charge reversal of X–Y linker
acidic residue stretch
Solvent-exposed basic residues
on TIM barrel
X–Y linker acidic stretch and
solvent-exposed basic residues on
TIM barrel

Predicted Result

decreased thermal stability
increased basal activity
decreased thermal stability
increased basal activity
decreased thermal stability
increased basal activity.
Thermal stability and basal
activity comparable to
PLCb3-∆847
Thermal stability and basal
activity comparable to
PLCb3-∆847
decreased thermal stability
increased basal activity

decreased thermal stability
increased basal activity
decreased thermal stability
increased basal activity
Thermal stability and basal
activity comparable to
PLCb3-∆892
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MATERIALS AND METHODS

Table 2.1: Phospholipase Cb 3 (PLCb3) Mutants Under Study
PLCb3 mutants included in this study are listed below. The short name is used throughout
the thesis for simplicity and clarity.
PLCb3 Mutant
PLCb3-D847 (residues 10-847)
E556-566K
K601E/R611E/K613E/K624E
K367E/K420E/K601E/K610E/R611E/K613E/K624E
E556-566K/K601E/R611E/K613E/K624E
E556-566K/
K367E/K420E/K601E/K610E/R611E/K613E/K624E
E556-566A
PLCb3-D892 (residues 10-892)
E556-566K
K601E/R611E/K613E/K624E
E556-566K/K367/420.601.610.611.613.624E

2.1

Short Name
PLCb3-D847
PLCb3-D847EK
PLCb3-D847KE
PLCb3-D847KE 3KE
PLCb3-D847FLIP
PLCb3-D847FLIP 3KE
PLCb3-D847EA
PLCb3-D892
PLCb3-D892EK
PLCb3-D892KE
PLCb3-D892FLIP

Mutagenesis, Expression and Purification of Human PLCb3 Variants
cDNA encoding human PLCb3-D847 (residues 10-847) and PLCb3-D892 (residues

10-892) were previously subcloned into the pFastBac Dual (Invitrogen) vector. The
following mutations were introduced using the QuikChange Site-Directed mutagenesis kit
(Stratagene, San Diego, CA) or the Q5 Site-Directed Mutagenesis Kit (New England
Biolabs, Ipswich, MA): PLCb3-D847EK, PLCb3-D847KE, PLCb3-D847FLIP, PLCb3D847EA, PLCb3-D847KE 3KE, PLCb3-D847FLIP 3KE, PLCb3-D892EK, PLCb3-D892KE, and
PLCb3-D892FLIP. All mutations were sequenced over the entire open reading frame.
Baculoviruses were generated in High Five cells using previously described methods (Lyon
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et al. 2014). Cells were infected with baculovirus (assumed MOI=1) and harvested after
40-45 hours of infection. Cell pellets were flash frozen in liquid nitrogen.
Cells were thawed and resuspended in lysis buffer (20 mM HEPES, pH 8.0, 200
mM NaCl, 10 mM b-mercaptoethanol, 0.1 mM EDTA, 0.1 mM EGTA, and Roche EDTAfree protease inhibitor at one third concentration) and dounced to homogeneity on ice. The
lysate was centrifuged at 100,000 x g for 1 hour at 4 °C. The supernatant was filtered with
a 0.2 µm glass fiber filter (Millipore, Billerica, MA) and loaded on to a Ni-NTA column
(Roche, Basel, Switzerland) pre-equilibrated with Buffer A (20 mM HEPES, pH 8, 100
mM NaCl, 10 mM b-mercaptoethanol, 0.1 mM EGTA, 0.1 mM EDTA). The column was
washed with 10 column volumes of Buffer A, followed by 10 column volumes of Buffer
A supplemented with 10 mM imidazole and 300 mM NaCl. PLCb3 variants were eluted
with Buffer A supplemented with 200 mM imidazole, concentrated to 1 mL, and filtered
with a 0.2 µm filter (Millipore). The concentrated sample was then applied to tandem
Superdex S200 columns (GE Healthcare) pre-equilibrated with S200 Buffer (20 mM
HEPES, pH 8, 200 mM NaCl, 2 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA). Fractions
corresponding to the protein peak were pooled, concentrated, and flash frozen in liquid
nitrogen for use in biochemical assays.

2.2

[3H]-PIP2 Liposome-Based Activity Assay
The basal activity of some PLCb3 variants was determined by quantifying the

amount of [3H]-IP3 produced from [3H]-PIP2-containing liposomes (Ghosh and Smrcka,
2004; Lyon et al. 2011). Liposomes containing 200 µM of hen egg white
phosphatidylethanolamine, 50 µM porcine brain phosphatidylinositol 4,5-bisphosphate
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(Avanti Polar Lipids, Alabaster, AL), and ~4000-8000 counts per minute [3H]-labeled PIP2
were combined and dried under nitrogen. Lipids were resuspended via sonication in 312
µL sonication buffer (50 mM HEPES, pH 7, 80 mM KCl, 2 mM EGTA and 1 mM DTT).
Phospholipase activity was assayed at 30 °C in 50 mM HEPES, 80 mM KCl, 15 mM NaCl,
0.83 MgCl2, 2.5 mM EGTA, 0.2 mM EDTA, 3 mM DTT, 1 mg/mL BSA with ~200 nM
free Ca2+. Control experiments included the same components, but Ca2+ was omitted. BSA
(100 µL of 10 mg/mL) and 10% (w/v) ice-cold trichloroacetic acid were added to terminate
reactions. After centrifugation at 8000 x g for 5 minutes, free [3H]-IP3 from the supernatant
was measured by scintillation counting (Gutierrez and Northup, 1995; Ghosh and Smrcka,
2004). Protein concentrations were optimized such that activity increased linearly over the
time course of the assay. Concentrations assayed were: 4 ng/µL PLCb3-D847, 0.25 ng/µL
PLCb3-D847 EK, 4 ng/µL PLCb3-D847 FLIP, 6 ng/µL D847 KE. At least three
independent experiments were performed in duplicate for each variant, using protein from
at least two protein preparations.

2.3

Inositol Phosphate-One Assay (IP1)
PLCb3-D847 and variants were assayed for activity using a modified version of the

IP-One assay (IP-One Gq Kit, Cisbio, Bedford, MA), a homogeneous time-resolved
fluorescence (HTRF) assay. Liposomes containing 100 µM hen egg white
phosphatidylethanolamine and 250 µM soy phosphatidylinositol (Avanti Polar Lipids,
Alabaster, AL) were combined and dried under nitrogen. The dried lipids were resuspended
in sonication buffer (1 mM DTT, 3 mM EGTA, 80 mM KCl, 50 mM HEPES, pH 7) by
vortexing and incubated at room temperature for 5 minutes prior to sonication. PLCb3
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variant activity was assayed at 37 ˚C in 50 mM HEPES, pH 7, 80 mM KCl, 16.67 mM
NaCl, 0.83 mM MgCl, 3 mM DTT, 1 mg/mL BSA, and ~2.26 mM free Ca2+. Varying
amounts of PLCb3 variants were used to determine phospholipase activity in the linear
range over a 10-minute time course. Protein were used at concentrations of: 15 ng/µL
PLCb3-D847, 0.25 ng/µL PLCb3-D847EK, 4 ng/µL PLCb3-D847KE 3KE, 4 ng/µL PLCb3D847FLIP, 4 ng/µL PLCb3-D847EA, 4 ng/µL PLCb3-D847FLIP 3KE, and 8 ng/µL D847KE.
Control experiments included the same components except for free Ca2+. Reactions were
initiated by the addition of lipids to tubes and placed at 37 ˚C, with samples taken every 2
minutes over a 10-minute incubation period. Reactions were quenched by the direct
addition of 5 µL of quench buffer (100 mM HEPES, pH 7, 160 mM KCl, 1 mM DTT, 210
mM EGTA). Samples for each time point were transferred to a 384-well low volume flat
bottom microplate (Greiner Bio-One). D2-labeled IP1 (acceptor; Cisbio) and anti-IP1cryptate (donor; Cisbio) reagents were incubated separately with detection buffer (Cisbio)
and filtered with a 0.2 µm filter (Millipore) prior to adding them to the microplate. 3 µL of
filtered D2-labeled IP1, followed by 3 µL anti-IP1-cryptate, was added to each sample, as
per manufacturer’s instructions, and incubated in the dark for 1 h at room temperature. The
microplate was then centrifuged at 1,000 x g for 1 minute and fluorescence was measured
using a Synergy 4 plate reader (BioTek). IP1 production was quantitated by measuring
fluorescence at 665 nm and 620 nm, calculating their ratio, and extrapolating the total IP1
concentration using a standard curve (Microsoft Excel; GraphPad Prism 7). Each PLCb3
variant was assayed at least three times in duplicate using protein from at least two separate
purifications.
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2.4

Differential Scanning Fluorimetry
The melting temperature (Tm) of all PLCb3 variants was determined as previously

described (Niesen et al. 2007; Lyon et al. 2011). PLCb3 variants were filtered through a
0.2 µm filter (Millipore) prior to use. A final concentration of 0.2-0.5 mg/mL of each
PLCb3 variant was assessed in the presence of 5 mM CaCl2, 5X SYPRO Orange
(Molecular Probes, Eugene, OR), and S200 buffer in a 70 µL master mix. The master mix
was divided into 3 wells, each containing 20 µL in a 96-well MicroAmp Optical reaction
plate and sealed with MicroAmp Optical Adhesive film (Applied Biosystems, Waltham,
MA) on ice. Thermal denaturation was monitored by measuring the change in fluorescence
from 25˚C - 95˚C using a ViiA7 qPCR (Thermo Fisher). The Tm values were determined
by fitting the thermal denaturation curves to a Boltzmann sigmoidal function (GradPad
Prism 7). PLCb3 variants were examined in triplicate at least three times from two different
protein purifications.

2.5

Liposome Pulldown Assay
200 µM egg white phosphatidylethanolamine and 100 µM porcine brain

phosphatidylinositol 4,5-bisphosphate (Avanti Polar Lipids, Alabaster, AL) were
combined, dried under nitrogen, and stored at -20 °C. Liposomes were resuspended in 312
µL sonication buffer (1 mM DTT, 3 mM EGTA, 80 mM KCl, 50 mM HEPES pH 7) and
sonicated. All PLCb3-D847 variants were filtered through a 0.2 µm filter (Millipore) prior
to use. 125 pmol of each PLCb3-D847 variant was incubated with 65 µL of PE:PIP2
liposomes or 65 µL sonication buffer, for a final reaction volume of 100 µL and incubated
for 1 hour on ice. Samples were then centrifuged at 119,000 x g for 1 hour at 4 °C. The
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supernatant from each sample was then transferred to a 1.7 mL Eppendorf tube, and the
remaining pellet was resuspended in 100 µL sonication buffer. All samples were kept on
ice. A total of 10 pmol of each PLCb3-D847 variant incubated with or without liposomes
was loaded on a 10% SDS-PAGE gel, electrophoresed at 240 V for 1 hour, and stained
with Coomassie Blue. Band intensity was quantified using ImageJ (NIH). Data was
normalized by comparing the band density of the supernatant or pellet in the presence of
liposomes to the control, which lacked liposomes. Each PLCb3 variant was examined at
least three times from two different protein preparations.
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ELECTROSTATIC REGULATION

3.1

Charge Reversal Mutations Decrease Thermal Stability of PLCb3-D892 and
PLCb3-D847
To determine if mutations that perturb electrostatic interactions affect global

thermal stability, differential scanning fluorimetry (DSF) (Mezzasalma et al., 2007; Niesen
et al., 2007) was used to measure the melting temperatures (Tms) of the PLCb3 variants. In
these experiments, the protein is incubated with a fluorescent dye and heated. As the
protein denatures, the dye irreversibly binds to hydrophobic areas of the protein as it
unfolds, resulting in increased fluorescence (Niesen et al, 2007). The inflection point of the
denaturation curve corresponds to the Tm of the protein. Representative curves for the
PLCb3-D847 and PLCb3-D892 variants are shown in Figure 3.1 A and B. The Tm of
PLCb3-D847 and PLCb3-D892 were 54 ± 0.3 °C and 59 ± 0.5 °C, respectively (Table 3.1),
where PLCb3-D892 has a higher Tm due to the presence of the proximal CTD1,2. The
PLCb3-D847EK or PLCb3-D892EK variants, whose acidic stretch was mutated to
polylysine, had Tms of 53 ± 0.2 °C and 59 ± 0.2 °C, similar to PLCb3-D847 or PLCb3D892, respectively (Figure 3.1 and 3.2; Table 3.1). In contrast, PLCb3-D847KE and PLCb3D847KE 3KE, which contain lysine to glutamate mutations on the TIM barrel domain, had
Tm values of 50 ± 0.7 °C and 55 ± 0.2 °C. Therefore, mutation of the TIM barrel alone
significantly decreased the Tm by 4-7 °C, relative to PLCb3-D847 (Table 3.1). PLCb3
variants that contained both X–Y linker and TIM barrel charge reversal mutations, PLCb3D847FLIP and PLCb3-D892FLIP, also had significantly decreased Tm values of 47 ± 0.4 °C
and 53 ± 0.7 °C, respectively, compared to the control proteins (Table 3.1). The role of
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three other solvent-exposed basic residues of the TIM barrel (Lys367, Lys420, and
Lys610), was also evaluated in PLCb3-D847FLIP and PLCb3-D847KE. These variants had
Tm values of 47 ± 0.7 °C and 47 ± 0.2 °C, respectively, which are again significantly lower
(~8 °C) than PLCb3-D847. Finally, introduction of polyalanine residues to replace the
acidic residue stretch of the X–Y linker in PLCb3-D847EA also resulted in a significant
decrease in thermal stability of 4 °C, with a Tm of 50 ± 0.1 °C (Table 3.1).
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A

B

Figure 3.1: Thermal Stability of PLCb3-D847 and PLCb3-D892 Variants
Representative thermal denaturation curves of PLCb3-D847 and PLCb3-D892 variants. A.
PLCb3-D847 charge reversal mutations and B. PLCb3-D892 charge reversal mutations
decrease the melting temperature relative to PLCb3-D847 or PLCb3-D892.
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A

B

Figure 3.2: Charge Reversal Mutations Destabilize PLCb3-D847 and PLCb3-D892
A. Charge reversal mutations in the X–Y linker and/or the surface of the TIM barrel domain
decrease thermal stability relative to PLCb3-D847. B. Charge reversal mutations in the X–
Y linker and/or the surface of the TIM barrel domain decrease thermal stability relative to
PLCb3-D892. PLCb3-D892 variants have a higher Tm compared to PLCb3-D847 because
they still retain the proximal CTD, thus stabilizing the enzyme. Data was analyzed using
an ordinary one-way ANOVA followed by Dunnett’s multiple comparisons test (GraphPad
Prism 7). **** p-value < 0.0001 significant relative to PLCb3-D847 (A) or PLCb3-D892
(B). PLCb3-D892 and PLCb3-D892KE variants were examined at least three times in
triplicate from one protein preparation, and all other PLCb3 variants were examined at
least three times in triplicate from one protein preparation.
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Table 3.1: PLCb3-D847 and PLCb3-D892 Variant Tm Values
Melting temperatures represent the mean ± SEM from at least three experiments in
triplicate from two different protein preparations. a Significant relative to PLCb3-D847
(p-value < 0.0001). b Significant relative to PLCb3-D892 (p-value < 0.0001).

3.2

PLCb3 Variant

N

Tm (°C)

PLCb3-∆847
PLCb3-∆847EK
PLCb3-∆847KE
PLCb3-∆847KE 3KE
PLCb3-∆847FLIP
PLCb3-∆847FLIP 3KE
PLCb3-∆847EA
PLCb3-∆892
PLCb3-∆892EK
PLCb3-∆892KE
PLCb3-∆892FLIP

17
6
4
4
5
4
5
5
3
3
5

54 ± 0.3
53 ± 0.2
50 ± 0.7a
46 ± 0.2a
47 ± 0.4a
47 ± 0.2a
50 ± 0.1a
59 ± 0.5a
59 ± 0.2a
55 ± 0.2b
53 ± 0.7b

Charge Reversal Mutations in PLCb3-D847 and PLCb3-D892 Affect PIP2
Hydrolysis Rate
To determine the effect of the charge reversal mutations on enzymatic activity, the

rate of [3H]-PIP2 hydrolysis for some PLCb3 variant proteins was measured. PLCb3-D847
and PLCb3-D892 had basal activities of 28 ± 1.9 and 0.7 ± 0.2 nmol IP3/time/nmol PLCb3
variant, respectively, consistent with previously reported activities in Lyon et al., 2014.
PLCb3-D847EK and PLCb3-D892EK had specific activities of 170 ± 13.4 and 91 ± 7.4 nmol
IP3/time/nmol PLCb3 variant, 6 and 120-fold greater activities compared to PLCb3-D847
and PLCb3-D892 (Table 3.2). PLCb3-D847 KE and PLCb3-D892 KE have basal activities of
1.8 ± 0.1 and 1.1 ± 0.2 nmol IP3/time/nmol PLCb3 variant, respectively. However, only
PLCb3-D847KE had significantly decreased activity relative to the control (Figure 3.3;
Table 3.2). Finally, PLCb3-D847FLIP and PLCb3-D892FLIP had basal activities of 12 ± 1.3
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and 7.1 ± 1.2 nmol IP3/time/nmol PLCb3 variant, comparable to their respective control
proteins (Figure 3.3; Table 3.2).
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Figure 3.3: Basal Activity of PLCb3 Variants Measured by [3H]-PIP2 Hydrolysis
A significant increase of activity is observed when the acidic stretch of the X–Y linker is
mutated to basic residues (PLCb3-D847EK and PLCb3-D892EK). Mutations in the TIM
barrel significantly decrease basal activity relative to PLCb3-D847. PLCb3-D892 and
PLCb3-D892KE variants were examined at least three times in duplicate from one protein
preparation, and all other PLCb3 variants were examined at least three times in duplicate
from two different protein preparations. Data was analyzed using an ordinary one-way
ANOVA followed by Dunnett’s multiple comparisons test (GraphPad Prism 7) and are
shown as mean ± SEM (****p-value < 0.0001; * p-value < 0.05). These experiments
were performed by A. M. Lyon, E. E. Garland-Kuntz, and M. Sieng.
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Table 3.2: PLCb3 Variant Specific Activity As Measured by [3H]-PIP2 Hydrolysis
Data represent at least three individual experiments measured in duplicate ± SEM, from at
least two purifications. a Significant relative to PLCb3-D847, p-value < 0.0001. b
Significant relative to PLCb3-D847, p-value < 0.05. c Significant relative to PLCb3-D892
p-value < 0.0001.
PLCb3 Variant

N

nmol IP3/time/nmol PLCb3

PLCb3-∆847
PLCb3-∆847EK
PLCb3-∆847KE
PLCb3-∆847FLIP
PLCb3-∆892
PLCb3-∆892EK
PLCb3-∆892KE
PLCb3-∆892FLIP

4
4
4
6
3
5
5
4

28 ± 1.9
170 ± 13.4a
1.8 ± 0.1b
12 ± 1.3
0.7 ± 0.2b
91 ± 7.4a,c
1.1 ± 0.2b
7.1 ± 1.2

3.3

PLCb3-D847 Activity as Measured by Phosphatidylinositol (PI) Hydrolysis
The basal activity of all the PLCb3-D847 variants was quantified using a modified

version of the IP-One assay (Cisbio), which detects the accumulation of inositol-1phosphate produced upon phosphatidylinositol (PI) hydrolysis (Hoffman and Majerus,
1982; Serunian et al., 1989). PLCb3-D847 has a specific activity of 1.1 ± 0.1 IP1/time/nmol
PLCb3 variant under these conditions.. PLCb3-D847EK has an activity of 52 ± 12
IP1/time/nmol PLCb3 variant, a ~47-fold increase in activity compared to the PLCb3-D847
(Figure 3.4; Table 3.3). However, PLCb3-D847KE has an activity of 0.9 ± 0.2 IP1/time/nmol
PLCb3, PLCb3-D847FLIP has an activity of 1 ± 0.2 IP1/time/nmol PLCb3 variant, PLCb3D847FLIP 3KE has an activity of 0.8 ± 0.1 IP1/time/nmol PLCb3 variant, and PLCb3-D847KE
3KE

has an activity of 0.7 ± 0.1 IP1/time/nmol PLCb3 variant, none of which are

significantly different from PLCb3-D847. Therefore, under these conditions, mutation of
the TIM barrel alone or in combination with the X–Y linker has no impact on specific
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activity. PLCb3-D847EA has a specific activity of 2.9 ± 0.3 IP1/time/nmol PLCb3 variant,
which is increased relative to the other variants, but is not significantly different from
PLCb3-D847.
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Figure 3.4: PLCb3-D847 Variant Specific Activity As Measured by PI Hydrolysis
Only the PLCb3-D847EK variant has significantly increased basal activity relative to
PLCb3-D847 when PI is used as a substrate. Data was analyzed using an ordinary oneway ANOVA followed by Dunnett’s multiple comparisons test (GraphPad Prism 7) and
represent the mean ± SEM. Each PLCb3-D847 variant was examined at least three times
in duplicate from two different protein preparations. (**** p < 0.0001)

Table 3.3: IP1 PLCb3-D847 Variant Specific Activities
Data represent at least four individual experiments measured in duplicate ± SEM, from at
least two purifications. a p-value < 0.0001 significant compared to PLCb3-D847.
PLCb3 Variant

N

nmol IP1/time/nmol PLCb3

PLCb3-∆847
PLCb3-∆847EK
PLCb3-∆847EA
PLCb3-∆847KE
PLCb3-∆847FLIP
PLCb3-∆847FLIP 3KE
PLCb3-∆847KE 3KE

9
4
7
5
7
4
5

1.1 ± 0.1
52 ± 12a
2.9 ± 0.3
0.9 ± 0.2
1 ± 0.2
0.8 ± 0.1
0.7 ± 0.1
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3.4

PLCb3-D847 Charge Reversal Variants Have Altered Binding to PE:PIP2
Liposomes
The increased basal activity observed for the PLCb3-D847 charge reversal variants

may be due to enhanced binding to liposomes. To test this hypothesis, a liposome binding
assay was used to assess the membrane binding capability of the PLCb3-D847 variants.
Purified PLCb3-D847 variant proteins were incubated with PE:PIP2 liposomes or buffer,
centrifuged, and supernatant and pellet were analyzed by SDS-PAGE. The liposome
composition is identical to that used in the [3H]-PIP2 hydrolysis activity assay. The band
intensity of the supernatant or pellet sample after incubation was liposomes was normalized
to the control pellet, which contained only protein and buffer. Representative SDS-PAGE
liposome pulldown results are shown in Figure 3.5.
PLCb3-D847 was found in both the supernatant and the pellet fractions in the
presence of liposomes (normalized pellet to supernatant ratio of 0.5 ± 0.1), consistent with
the protein binding weakly to liposomes. PLCb3-D847KE and PLCb3-D847KE 3KE were also
found in both the supernatant and pellet fractions in the presence of liposomes (normalized
pellet to supernatant ratio of 0.4 ± 0.2 and 0.7 ± 0.1, respectively), consistent with these
variants showing weak binding to liposomes. In contrast, PLCb3-D847EK, PLCb3D847FLIP, and PLCb3-D847FLIP

3KE

were all found predominantly in the pellet in the

presence of liposomes (normalized pellet to supernatant ratio of 5.8 ± 0.3, 5.5 ± 0.3, and 4
± 0.4, respectively), consistent with these variants having increased binding capabilities
(Figure 3.6; Table 3.4).
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Figure 3.5: Representative SDS-PAGE Liposome Pulldown Results with PLCb3-D847
Variants
Purified PLCb3-D847 variants were incubated with (+) liposomes or buffer alone (–).
Following ultracentrifugation, samples of equal volume from the supernatant or
resuspended pellet fraction from each condition were analyzed by SDS-PAGE.
Supernatant (S) and pellet (P) samples were loaded on to 10% SDS-PAGE gels and stained
with Coomassie Blue. PLCb3-D847 has a molecular weight of 95.5 kDa.
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Figure 3.6: Quantitation of Liposome Binding by the PLCb3-D847 Variants
Band density from the SDS-PAGE gels was quantified using ImageJ, and the normalized
ratio of pellet to supernatant was calculated for each PLCb3-D847 variant. PLCb3-D847EK,
PLCb3-D847FLIP, and PLCb3-D847FLIP 3KE have a greater liposome binding capability than
the PLCb3-D847 control (****p-value < 0.0001). Each PLCb3-D847 variant was examined
at least three times from two different protein preparations. Data was analyzed using an
ordinary one-way ANOVA followed by a Dunnett’s multiple comparisons test (GraphPad
Prism 7).
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Table 3.4: Summary of the Normalized Pellet/Supernatant Ratios for the PLCb3-D847
Variants
Normalized pellet to supernatant ratios of PLCb3-D847 variants are summarized. a pvalue < 0.0001 significant compared to PLCb3-D847.
PLCb3 Variant
PLCb3-∆847
PLCb3-∆847EK
PLCb3-∆847EA
PLCb3-∆847KE
PLCb3-∆847FLIP
PLCb3-∆847KE 3KE
PLCb3-∆847FLIP 3KE

3.5

N
4
4
3
5
4
5
4

Normalized Pellet/Supernatant
0.5 ± 0.1
5.8 ± 0.3a
1.7 ± 0.5
0.4 ± 0.2
5.5 ± 0.3a
0.7 ± 0.1
4 ± 0.4a

Discussion of Results
Previous studies have shown that that PLCb3-D847 has higher basal activity and

decreased thermal stability compared to PLCb3-D892

(Lyon et al., 2014). These

observations are further supported by the data presented here (Figure 3.2, 3.3 and 3.4).
These differences are due to the presence of the autoinhibitory X–Y linker and Ha2’ helix
in PLCb3-D892 (Lyon et al., 2011), whereas PLCb3-D847 only contains the autoinhibitory
X–Y linker. Previous studies focused on autoinhibition have shown that deletions within
the X–Y linker increase basal activity, presumably due to loss of autoinhibition (Hicks et
al., 2008; Lyon et al., 2014; Charpentier et al., 2014). I hypothesized that reversing the
charge reversal of the X–Y linker acidic stretch or solvent exposed basic residues of the
TIM barrel domain would increase PLCb3 basal activity and decrease thermal stability,
due to the loss of intramolecular electrostatic interactions.
I first evaluated the importance of the acidic stretch of the X–Y linker by generating
the

PLCb3-D847EK and PLCb3-D892EK mutants, where the charge of the acidic stretch

is reversed. These variants did not have significantly altered thermal stability compared to
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PLCb3-D847 or PLCb3-D892, respectively (Figure 3.2), which contradicts the hypothesis
that disruption of the electrostatic interactions between the X–Y linker and the TIM barrel
would result in decreased thermal stability. However, both variants had significantly
increased specific activities (Figure 3.3). While this increased activity is consistent with
loss of autoinhibition, it could also be due to an improved ability of these variants to bind
their liposome substrates. Indeed, the PLCb3-D847EK variant was predominantly found in
the pellet in liposome pulldown assays (Figure 3.5 and 3.6).
I next assessed whether charge reversal mutations of the solvent-exposed basic
residues of the TIM barrel changed thermal stability and/or activity. PLCb3-D847KE,
PLCb3-D847KE 3KE and PLCb3-D892KE all had significantly decreased thermal stability as
compared to PLCb3-D847 (Figure 3.2). PLCb3-D847KE and PLCb3-D847KE

3KE

were

assayed for their ability to hydrolyze PI, but had specific activities comparable to PLCb3D847 (Figure 3.4). Finally, in the liposome pulldown assay, these variants were found to
similar extents in both in the supernatant and pellet fractions upon incubation with PE:PIP2
liposomes, again similar to PLCb3-D847 (Figure 3.5 and 3.6). Therefore, while the TIM
barrel charge reversal mutations may destabilize the enzyme as measured by thermal
stability, they are insufficient to release autoinhibition and increase specific activity.
The combined charge reversal mutants PLCb3-D847FLIP, PLCb3-D892FLIP, and
PLCb3-D847FLIP 3KE all have significantly decreased thermal stability compared to PLCb3D847 and PLCb3-D892 (Figure 3.2). Again, these mutations did not have significantly
altered specific activities when assayed for the rate of PIP2 or PI hydrolysis compared to
the controls (Figures 3.3, 3.4). Liposome pulldown assays reveal that these variants are
predominantly in the pellet in the presence of liposomes, consistent with increased binding
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(Figure 3.5 and 3.6). Therefore, the increase in specific activity may be due in part to better
liposome binding, but may also be due to restoration of autoinhibitory interactions between
the acidic stretch of the X–Y linker and the TIM barrel.
Finally, the PLCb3-D847EA variant was assessed for thermal stability and activity.
In this variant, the acidic stretch of the X–Y linker was mutated to alanine residues, which
eliminates the negative charge without introducing any new electrostatic surfaces. PLCb3D847EA had a significantly decreased thermal stability compared to PLCb3-D847 (Figure
3.2). The rate of PI hydrolysis was also assessed, but while its activity is higher than the
other PLCb3-D847 variants, it does not reach significance (Figure 3.4). Preliminary
pulldown liposome assays of PLCb3-D847EA reveal that it is found in both the supernatant
and pellet fractions in the presence of liposomes, suggesting that the increased activity may
be due primarily to loss of intramolecular electrostatic interactions. However, further
experiments are required to confirm these findings.
While previous studies have proposed a correlation between decreased thermal
stability and increased PLCb activity (Lyon et al., 2014), this was not observed in this
thesis. The trend between increased basal activity and decreased thermal stability in
previous studies was observed using PLCb3 deletion mutants (Lyon et al., 2011 and 2014),
as opposed to the charge reversal mutation strategy used here. This difference could result
in subtle changes in protein fold and/or function, however further studies are needed to
clarify this possibility. Ultimately, understanding the mechanisms regulating PLCb3 will
contribute to a greater understanding of the role of this enzyme in cardiovascular function
and disease.
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3.6

Future Directions
The studies described in this thesis support the hypothesis that intramolecular

electrostatic interactions contribute to the basal regulation of PLCb3. However, additional
residues on the TIM barrel domain may contribute to interactions with the acidic stretch of
the X–Y linker. In addition, the relative importance of each conserved, basic residue on the
TIM barrel surface to autoinhibition is unknown, representing one direction for future
studies.
In addition, the role of the autoinhibitory Ha2’ helix with respect to the electrostatic
interactions has not been fully characterized. Comparing the thermal stabilities, basal
activities, and liposome binding abilities of PLCb3-D892 charge reversal variants to those
of the PLCb3-D847 variants may reveal if the Ha2’ helix contributes to the electrostatic
regulation of PLCb.
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